Abstract
In a prospective study of 50 consecutive fine-needle samples of breast cancer, determination of estrogen and progesterone receptors was performed by separate immunocytochemical and biochemical assays. Comparisons of immunocytochemical assays with biochemical assays were obtained in 42 cases (84%) for both steroid receptors and showed significant relationships for estrogen receptor (P less than 0.001, r = 0.85) and progesterone receptor (P less than 0.001, r = 0.89) when the percentage of labeled nuclei (immunocytochemical assay index) was considered. In addition, DNA flow cytometric analyses were performed on fine-needle samples in 34 cases, with measurable DNA ploidy and S-phase fraction in 33 (97%) and 31 cases (91%), respectively. These results show that (1) estrogen and progesterone receptor immunocytochemical assays are valuable tools for steroid receptor determination, and that (2) on the same fine-needle samples of breast cancer DNA flow cytometric analysis may be performed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
